AstraZeneca OVERVIEW SUMMARY

AstraZeneca (NYSE: AZN) headquartered in London works in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory inflammation, and anti-infectives.

Products include:

• Arimidex for hormonal breast cancer
• Crestor for cholesterol levels
• Nexium for acid-related diseases
• Seroquel for schizophrenia and bipolar mania
• Symbicort for asthma

Other areas of foci include medical devices and implants for use in urology, surgery, and odontology. In addition, Astrazeneca develops and manages out-patient cancer centers in the US.

Some strategic alliances include:

• AtheroGenics (NASDAQ: AGIX)
  
• Pozen (NASDAQ: POZN)
  
• Bristol-Myers Squibb (NYSE: BMY)
  
• Cambridge Antibody Technology Group
• KuDOS Pharmaceuticals
• WuXi Pharmatech (NYSE: WX)
  
• ChemBridge
• Peking University Third Hospital

Some collaborators include:

• Abgenix (NASDAQ: AMGN)
  
• Abbott Laboratories (NYSE: ABT)
  
• Argenta Discovery
• Beatson Institute for Cancer Research
• BioFocus
• Biovator
• Cancer Research Technology Limited
• Dyax Corp (NASDAQ: DYAX)
  
• Effector Cell Institute
• Palatin Technologies (NYSE: PTN)
  
• Protherics (NASDAQ: PTIL)
  
• Schering Plough (NYSE: SGP)
  
• Silence Therapeutics
• Targacept (NASDAQ: TRGT)